Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry.
|
21088392 |
2011 |
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke.
|
20212195 |
2010 |
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator.
|
19095969 |
2009 |
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study.
|
18753474 |
2008 |
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials.
|
18369171 |
2008 |
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Intravenous recombinant tissue plasminogen activator improves arterial recanalization rates and reduces infarct volumes in patients with hyperdense artery sign on baseline computed tomography.
|
18346647 |
2008 |
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Assessment of suitability of thrombolysis in middle cerebral artery infarction: a proof of concept study of a stereologically-based technique.
|
17690543 |
2007 |
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Argatroban tPA stroke study: study design and results in the first treated cohort.
|
16908730 |
2006 |
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
|
16126134 |
2005 |
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Our findings suggest that endogenous tPA plays an important role in heparin-produced cerebral hemorrhage via MMP9 induction and activation.
|
16190367 |
2005 |
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Essential role of endogenous tissue plasminogen activator through matrix metalloproteinase 9 induction and expression on heparin-produced cerebral hemorrhage after cerebral ischemia in mice.
|
14630814 |
2004 |
Cerebral Hemorrhage
|
0.500 |
Therapeutic
|
phenotype |
RGD |
Tissue plasminogen activator for the treatment of intraventricular hematoma: the dose-effect relationship.
|
12220690 |
2002 |
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey.
|
11940547 |
2002 |
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study.
|
11113218 |
2000 |
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Brain hemorrhages after rt-PA treatment of embolic stroke in spontaneously hypertensive rats.
|
10501537 |
1999 |
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors.
|
9836764 |
1998 |
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Complications from the use of thrombolytic agents in patients with cocaine associated chest pain.
|
8969996 |
1997 |
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Tissue plasminogen activator for acute ischemic stroke.
|
7477192 |
1995 |
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke.
|
1579960 |
1992 |
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Severe acute myocardial infarction during a staphylococcal septicemia with meningoencephalitis. A possible contraindication to thrombolytic treatment.
|
1430592 |
1992 |
Cerebral Hemorrhage
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.
|
1899364 |
1991 |